Skip to main content
Premium Trial:

Request an Annual Quote

'A Lie and a Sham'

DrugMonkey says that co-first authorship on scientific papers is "a lie and a sham and an embarrassment to our profession." PIs and lab heads should make it clear to the researchers working under them that there is no such thing as "co-equal" and that the very idea is a "valueless sop," DrugMonkey adds.

It should be made clear to any co-authors that such a note on a paper won’t bee seen as equal by the academic community, DrugMonkey says, adding that co-authors should have to sign a statement to that effect and know that it may affect their careers.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.